gimli
JOHNPHARM stock AI analysis

JOHNPHARM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

JOHNSON PHARMACARE LIMITE is a stock in Unclassified. This Gimli page shows the latest available JOHNPHARM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Price
₹n/a
1W return
n/a
1M return
n/a
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
n/a
Turnover
₹n/a

Why it can matter in screens

Quick Answers

What is the latest JOHNPHARM stock price?

The latest stored price for JOHNPHARM is Rs n/a as of the latest available market snapshot.

Is JOHNPHARM above its 50DMA and 200DMA?

JOHNPHARM is 50DMA unavailable, 200DMA unavailable. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are JOHNPHARM PE, ROE and ROCE?

JOHNPHARM has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.

How has JOHNPHARM performed recently?

JOHNPHARM has returned n/a over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

No recent data available.

Annual income statement

No recent data available.

Balance sheet

No recent data available.

Cash flow

No recent data available.

Shareholding Trend

No recent data available.

Industry Peers

No recent data available.

Try these prompts

Related screen ideas

Data snapshot: latest available. Not investment advice.